logo
Best NAD Supplements for Longevity, According to Experts: Wonderfeel

Best NAD Supplements for Longevity, According to Experts: Wonderfeel

Yahoo22-04-2025
San Francisco, April 22, 2025 (GLOBE NEWSWIRE) --
Best NAD Supplements for Longevity, According to Experts: WonderfeelContent verified by BrandingEx solutions (support@brandingexperts.com)
As interest in longevity supplements surges, one molecule is drawing major attention: NAD. This cellular fuel, short for nicotinamide adenine dinucleotide, plays a critical role in energy production, DNA repair and healthy aging​. Beyond supporting energy and cognition, NAD enhances the body's ability to repair damage at a cellular level. This contributes to healthier skin, organs, and tissues as we age. Think of NAD as a molecular safeguard—working silently in the background to preserve function, delay the onset of age-related decline and help you feel younger, longer.
Unfortunately, our NAD levels decline steadily after 30, which researchers believe contributes to fatigue, slower metabolism, and other hallmarks of aging​. The good news? Boosting NAD through supplements like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) may help restore youthful levels, supporting better cellular health and vitality.
In this comprehensive guide, we'll explain what NAD is and why it matters for longevity, according to scientists. We'll dive into the science behind NAD supplements and how they support cellular health. Most importantly, we'll review the best NAD supplements available – including top-rated NMN capsules and NR formulations – with expert insights on their pros, cons, unique features, pricing, and evidence.
What is NAD?
NAD (nicotinamide adenine dinucleotide) is a vital coenzyme found in every cell of our bodies. Often described as the cell's 'energy currency,' NAD helps turn nutrients into cellular energy (ATP) and is required for over 500 enzymatic reactions​.
As we grow older, our natural production of NAD gradually slows down, and so do our NAD levels. This decline begins in our early 30s and continues steadily with age. By the time we hit 50, our NAD levels are typically reduced to about half of what they were in our early 20s. While this is a normal part of aging, it's also closely tied to the onset of cellular dysfunction that can pave the way for chronic conditions like cancer, metabolic disorders, and neurodegenerative diseases.
According to Dr. Andrew Salzman—a Harvard-trained physician-scientist and prolific inventor whose research includes pioneering work on PARP inhibition and NAD's role in DNA repair for BRCA-related cancers—NAD is nothing short of essential. In his words, it's the core of biology:It powers our energy systems. It helps protect against cancer. And it shields us from age-related decline.
Scientifically speaking, NAD enables the creation of ATP (the energy currency of our cells), activates PARP enzymes for DNA repair, and helps defend against oxidative stress, reducing the risk of inflammation, heart issues, gut problems, and more.
Leading longevity experts like Harvard geneticist Dr. David Sinclair have publicly championed NAD supplementation, and many research and studies suggest that maintaining higher NAD levels helps support healthy aging.
Benefits of NAD Supplements
Enhancing NAD levels may lead to numerous health benefits, such as increased energy, sharper cognitive function, support against metabolic issues, and better overall wellness. Below are the key benefits of NAD that are reshaping the way we think about longevity:
NAD Boosts Energy and Restores Vitality
Many individuals who start taking NAD supplements often experience a noticeable surge in energy. This rapid improvement happens because NAD is essential for powering mitochondrial energy production. As a result, people commonly report feeling less fatigued and more energized, allowing them to stay active and engaged throughout the day. NAD works by increasing cellular energy, which in turn reduces fatigue and enhances overall vitality.
In a study consisting of 48 amateur runners, participants who supplemented between 600-1200 mg of NMN, direct NAD precursor, were able to run longer distances and showed better aerobic performance, thanks to their skeletal muscles using oxygen more efficiently. Additionally, anecdotal evidence supports NAD supplements' reputation as a potent energy booster, with many users reporting higher energy levels after consistent use. Other benefits mentioned include relief from aches and pains, faster recovery from hangovers, and reduced jet lag. Since physical discomfort can diminish energy and limit activity—especially in older adults—NAD's ability to alleviate pain may also contribute to improved energy levels overall.
NAD Supports Healthy Aging and Cellular Resistance
Aging is now officially recognized by the World Health Organization as a health condition—one that involves a gradual decline in cellular function. At the heart of this process is a drop in systemic NAD levels. It's possible to replenish these levels and support the body's natural resilience to aging with NAD. Studies show that boosting NAD helps counteract age-related inflammation, restore mitochondrial function, and protect neurons, all of which are critical for maintaining vitality over time.
As we age, the body's ability to repair DNA naturally declines, increasing our susceptibility to diseases and the aging process. Increasing NAD stimulates the activity of sirtuins—powerful protein enzymes that regulate functions like aging, inflammation, detoxification, stress resistance, metabolism, and mitochondrial biogenesis.
Sirtuins not only help maintain cellular balance but also influence various genes and respond to environmental factors, making them essential for aging well. Their performance depends on the level of NAD, making it increasingly important to sustain higher NAD levels as we age. Through the activation of sirtuins, NMN can help lower the risk of age-related diseases and support a longer, healthier life by keeping cells in peak condition.
NAD Improves Hormonal Balance and Fertility
While the initial benefits of NAD supplements are promising, it's important to note that the more significant improvements come with long-term use. Over time, increasing NAD levels can lead to more profound enhancements in overall well-being, especially in key areas like reproductive health, hormonal balance, and fertility.
NAD has shown remarkable potential in improving fertility, particularly in aging women. NAD is essential for supporting the body's DNA repair processes, helping to keep the genetic material in oocytes intact and healthy. By preserving this genetic integrity, NAD not only enhances the quality of oocytes but also increases the likelihood of a successful and healthy pregnancy. Ultimately, protecting the DNA in these cells is vital for fertility and the healthy development of future generations. Hence, NAD supplements can extend the reproductive window by boosting ovarian function and maintaining oocyte health.
Hormonal balance is also the key to reproductive health and fertility, and NAD plays an important role in regulating levels of hormones such as estrogen. By supporting a healthy menstrual cycle, promoting regular ovulation, and aiding the development of ovarian follicles, NAD may help enhance fertility. While most of the research has been conducted on animal models, the results suggest a promising path for using NAD to improve hormonal balance and support reproductive health in women.
NAD Offers Better Sleep Quality
If you find yourself tossing and turning at night, desperately seeking a way to achieve restorative sleep and more energized days, NAD might be the solution you need. Research indicates that it significantly reduces insomnia, enhances sleep quality, and boosts daytime performance. With regular use, NMN can help reset your body's natural rhythm and regulate your internal clock.
NAD plays a crucial role in managing our sleep-wake cycles, with its levels varying throughout the day. Maintaining optimal NAD levels is essential for improving sleep quality and ensuring stable energy throughout the day.
By increasing NAD levels, these supplements enhance sleep quality and help regulate circadian rhythms. A 2022 study spanning 12 weeks found that older adults who took NAD supplements in the evening reported improved sleep quality and felt less fatigued during the day compared to those receiving a placebo. By stabilizing circadian rhythms, NAD seems to optimize our sleep cycles, making it easier to enjoy restful nights and feel revitalized during the day.
NAD Improves Metabolic Health and Aids Weight Management
Struggling with weight or sluggish metabolism? NAD may offer a surprising solution. Emerging research highlights its role in improving metabolic health by enhancing insulin sensitivity and energy utilization. In one clinical trial, women with prediabetes who took NMN for 10 weeks showed better muscle glucose regulation, indicating stronger insulin action and metabolic balance. Since both aging and poor diet can reduce NAD production, supplementation may help restore balance, reduce fat storage, and improve overall metabolic function. Whether you're trying to prevent metabolic disorders or simply improve how your body processes energy, NAD can be a powerful ally.
NAD Protects Skin and Enhances Hair Health
Who wouldn't want the secret to youthful, radiant skin? Research from Japan shows that NAD can reverse visible signs of aging by tackling glycation, a process that weakens collagen and elastin. By reducing advanced glycation end products (AGEs), NAD helps keep skin firm and smooth, especially in postmenopausal women. What's more, NAD boosts the production of hyaluronic acid and ceramides—key ingredients for deep hydration—giving your skin that plump, dewy look while enhancing elasticity and firmness.
But that's not all—NAD will offer protection from UV damage, strengthening your skin's DNA repair system and reducing the risk of photoaging and skin cancer through the nucleotide excision repair (NER) process. It also shows promise in minimizing stubborn age spots and hyperpigmentation by lowering melanin production in older skin cells. Whether you're aiming to defend your skin against the sun or even out your complexion, NAD could be the multitasking molecule your skincare routine has been missing.
Tired of battling hair loss and missing fuller, thicker hair? NAD can take care of both! A 2023 study revealed that NAD combats hair follicle shrinkage, thinning, and reduced density, delivering results similar to those of minoxidil, a popular hair loss treatment. This breakthrough suggests that NAD could be a game-changer for tackling hair loss while encouraging healthier, more vibrant hair growth.
NAD Enhances Cardiovascular Health and Heart Function
Your heart works around the clock, and NAD may be one of its strongest supporters. Research indicates that raising NAD levels can improve a wide range of heart-related conditions, including high blood pressure, ischemic heart disease, and various forms of cardiomyopathy. These benefits stem from NAD's role in promoting cellular repair, reducing oxidative stress, and improving mitochondrial performance within cardiac tissue.
Moreover, NAD activates sirtuins—enzymes that regulate inflammation, metabolic efficiency, and aging. This activation has downstream effects on vascular health, potentially reducing arterial stiffness and supporting a healthy heartbeat. In short, NAD doesn't just benefit your energy levels—it's working behind the scenes to support one of your most vital organs, too.
NAD Helps with Detoxification, Including Mold Exposure
If you've been exposed to mold or environmental toxins, your body relies on specific enzymes to break these compounds down. Many of these enzymes are NAD-dependent, meaning they require adequate NAD levels to function efficiently. By supplementing with NAD, you may improve your body's ability to detoxify and clear harmful substances like mycotoxins, which can otherwise disrupt hormone levels and immune function.
NAD's detoxifying properties are especially important for those living in damp environments or dealing with chronic inflammation related to mold exposure. Supporting NAD levels can strengthen your natural defense systems and help you recover from toxin-related fatigue or illness more effectively.
NAD Aids in Menopausal Changes of Body
As women navigate the challenges of menopause, symptoms like hot flashes, fatigue, and brain fog can disrupt daily life. One of the underlying causes is a drop in NAD levels, a molecule critical for cellular repair and energy. Boosting NAD offers a promising way to restore vitality during this stage of life. Findings suggest that it not only helps improve hormonal balance and cognitive function but also supports overall well-being, making it a powerful ally for women seeking relief from menopause-related discomfort.
Menopause also brings a decline in estrogen, which plays a vital role in managing inflammation and supporting cellular repair. Lower estrogen levels can lead to chronic inflammation and slower tissue recovery, resulting in joint pain, skin changes, and even cardiovascular risks. NAD helps by ramping up the body's ability to repair damaged cells and reduce inflammation, promoting healthier aging. Additionally, it supports bone health by lowering oxidative stress, which in turn could reduce the risk of osteoporosis.
Incorporating NAD supplements into your daily routine does more than just boost energy and vitality—it provides the body with the resources to age gracefully, helping you feel rejuvenated from within!
How do NAD Supplements Work?
If NAD itself is so important, why not just take NAD directly? The catch is that NAD is a large molecule that is not absorbed efficiently when taken orally or intravenously. It cannot enter inside the cells. Instead, most NAD supplements provide NAD precursors – smaller building blocks that your cells readily take up and convert into NAD. The two most popular are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). The body relies on these precursors which are absorbed more efficiently and utilize natural biological pathways to boost NAD levels within cells.
On a molecular level, both NMN and NR are safe. NMN serves as the direct building block for NAD, acting as an intermediary between NR and NAD. When you take NR, your body first needs to convert it into NMN before it can become NAD. While the conversion process is complex, taking NMN skips a step and gets you closer to the final stage of NAD production. That said, both NMN and NR have been clinically shown to effectively increase NAD levels in the body.
Another way people choose to boost NAD is through NAD IV therapy – intravenous infusions of NAD. NAD IV drips have popped up in wellness clinics, and thıs therapy has become pretty trendy lately, with some people turning to it for everything from more energy and better focus to weight loss, addiction and brain trauma recovery. Clinics tout IV NAD for things like addiction detox, chronic fatigue and even anti-aging skin treatments. If you do try NAD IV, know that it's costly (often $500+ per infusion), time-consuming, and any claimed benefits are largely anecdotal at this point. Does NAD IV really work? There's limited scientific evidence.
The idea is that by delivering NAD straight into your bloodstream, you'll get an instant boost to your cells. Sounds great in theory—but the research doesn't totally back it up yet. Studies are still pretty limited, and one even found that most of the NAD given through IV just got flushed out in urine, meaning it never made it to the cells where it's actually needed. Plus, some of the studies showing benefits are small or linked to the clinics offering the treatment, which makes them less trustworthy.
The most proven and researched way to raise NAD for longevity is by taking oral NAD precursor supplements like NMN or NR. These are generally safe and well-tolerated – human trials report minimal side effects even up to 2000 mg doses​ per day. These capsules are widely recognized for their convenient and non-invasive approach to increasing NAD levels, particularly appealing for those seeking a safe, gradual increase in NAD levels over time, making it well-suited for long-term use.
Best NAD Supplements of 2025
When choosing a high-quality NAD supplement, it's important to look beyond the marketing buzz and focus on a few key criteria. Purity and bioavailability should come first—supplements made with clean, transparent ingredients and formulated for effective absorption are more likely to deliver real benefits. Third-party testing and certifications, like NSF or GMP, are also good indicators that a product meets safety and quality standards. And while premium options may come with a higher price tag, it's worth weighing the cost against the dosage, number of servings, and overall formulation to make sure you're getting solid value for what you pay.
Below, we'll review the best NAD supplements available in 2025, according to experts and research, to help you choose the right option for your longevity goals.Wonderfeel Youngr™ NMN — Best Overall NAD Supplement
Wonderfeel Youngr™ NMN has quickly earned a reputation as one of the most advanced NAD supplements on the market – and for good reason. This patented formula was engineered by Dr. Andrew Salzman, a Harvard-trained MD with over 50 medical patents and nearly 30 years of experience in NAD and cellular health​.
Wonderfeel Youngr™ NMN stands out with its thoughtful formulation designed to boost cellular energy and support healthy aging. At its core is 900 mg of bioavailable NMN per serving—an effective, direct precursor for raising NAD levels in the body. But what really sets it apart is the synergy of its added ingredients: Hydroxytyrosol from olives, resveratrol from grapes, ergothioneine from mushrooms, and a daily dose of Vitamin D3. Together, these antioxidants not only promote NAD production, but also enhance mitochondrial function, improve energy metabolism, and support brain health.
The formula was developed and crafted with maximum absorption and purity in mind. Each batch is made in the USA, third-party tested, and comes with a certificate of analysis to ensure 99% purity. The supplement's antioxidant-rich blend helps protect against oxidative stress and inflammation—two major drivers of aging—making it a compelling option for anyone seeking long-term wellness support, not just a temporary energy lift.
Whether you're aiming to stay sharp, feel more energetic throughout the day, or simply age more gracefully, Wonderfeel Youngr™ NMN offers a comprehensive approach. Users may notice improved focus and mental clarity alongside physical vitality. With a price point starting at $73 for a monthly subscription, and the quality of ingredients and the science-backed formulation make it a worthy investment for those prioritizing long-term cellular health and overall well-being.
Subscribe and save $15 to experience the benefits of this top-tier supplement.
Wonderfeel NMN Capsuls™ Wonderfeel NMN Capsuls™ offers a clean, potent formula for those looking to boost their NAD levels and support healthy aging from the inside out. With 1000 mg of high-purity NMN per daily serving (two 500 mg capsules), this supplement focuses on delivering results without the noise of added fillers or unnecessary ingredients. This daily dosage aligns with the recommendations of longevity expert David Sinclair.
These capsules are ideal for those who want a simple, high-dose NAD boost backed by science. They're crafted with bioavailable NMN to ensure effective absorption, and the formula supports a range of benefits—from restoring skin elasticity and improving sleep quality to promoting organ health and brain function. The clean label and minimalist design make it especially appealing for users who want a targeted supplement they can trust, without unnecessary extras. Plus, the capsule format allows for flexibility: beginners can start with one 500 mg pill and gradually increase to the full 1000 mg dose as their body adjusts.
Price-wise, Wonderfeel NMN Capsuls™ stands out in the NAD category. At $58 for a one-time purchase or $52 with a subscription, it offers an unbeatable value—just $1.73 per gram of NMN, the lowest price point on the market. Because it's pure NMN, you can easily combine it with other supplements in your regimen (like resveratrol or quercetin) as you see fit. Wonderfeel's NMN Capsuls™ plays nicely in any longevity stack, and provide an accessible way to support vitality and well-being into the future.Frequently Asked Questions
What's the ideal daily dose for NAD supplements?
Most experts recommend taking between 900 to 1000 mg of NMN per day to see the best results from NAD supplements. Clinical studies show that doses in this range can significantly boost energy, improve endurance, and support healthy aging. While smaller doses like 300–600 mg can still offer benefits, higher amounts tend to be more effective. Research also shows that even doses up to 2000 mg daily are well-tolerated, so the ideal dose can vary based on your personal health goals.
When Should I Start Using a NAD Supplement?
It is often suggested to begin NAD supplementation around the age of 30, as this is when the body's natural production of NAD starts to decrease. This decline generally begins in the late 20s or early 30s and accelerates with age. NAD plays a critical role in various biological processes, including energy metabolism and DNA repair. As we age, maintaining adequate levels of NAD becomes increasingly important for sustaining cellular health.
Are NAD Supplements Safe?
Yes, NAD supplements like NMN and NR are considered safe when taken as directed. Clinical studies have shown they are well tolerated, even at higher doses up to 2000 mg, with only mild side effects like flushing or stomach discomfort reported in some cases. However, it's always best to consult your healthcare provider before starting any supplement, especially if you have existing health conditions.
When Will NAD Supplements Take Effect?
Most people begin to notice subtle improvements—like increased energy, better focus, or improved sleep—within a few weeks of consistent use. However, the most significant benefits, such as enhanced endurance, metabolic health, or cognitive support, tend to build gradually over time. NAD supplements work at the cellular level, so while changes may not be dramatic overnight, many users report meaningful improvements over the course of one to two months. Keeping a journal can help track these gradual shifts and better understand how your body responds.
Final Thoughts
NAD is more than a wellness trend; it is a cornerstone of cellular health and healthy aging. As research continues to highlight the link between NAD levels and longevity, more individuals are turning to trusted precursors like NMN and NR. Whether you're just beginning your journey or fine-tuning an existing routine, the best NAD supplements combine clean formulations, solid science, and proven efficacy. With the right support, you can take a proactive step toward feeling younger and staying healthier for longer.CONTACT: company website - getwonderfeel.com contact email - team@getwonderfeel.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Single-Use Bioreactors Market Size to Envision USD 22.46 Billion by 2034
Single-Use Bioreactors Market Size to Envision USD 22.46 Billion by 2034

Yahoo

time5 hours ago

  • Yahoo

Single-Use Bioreactors Market Size to Envision USD 22.46 Billion by 2034

The global single-use bioreactors market is valued at USD 5.38 billion in 2025 and is projected to expand to approximately USD 22.46 billion by 2034, advancing at a CAGR of 17.21% during the forecast period. Ottawa, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global single-use bioreactors market size was valued at USD 4.59 billion in 2024 and is projected to reach approximately USD 22.46 billion by 2034, growing at a CAGR of 17.21%, according to a study by Towards Healthcare, a sister company of Precedence Research. The accelerating demand for cell therapies and tailored medicine is contributing to the growth of the single-use bioreactors market. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America was dominant in the market share by 35% in 2024. Asia Pacific is expected to grow at the fastest CAGR during 2025-2034. By product, the single-use bioreactor systems segment led the market in 2024. By product, the single-use media bags segment is expected to witness significant expansion in the studied years. By type, the stirred tank SUBs segment dominated the market in 2024 and is expected to grow rapidly in the upcoming years. By cell type, the mammalian cells segment registered dominance in the single-use bioreactors market in 2024. By cell type, the bacterial cells segment is expected to grow at a notable CAGR in the predicted timeframe. By molecule type, the vaccines segment captured the largest share of the market in 2024. By molecule type, the gene modified cells segment is expected to register the fastest expansion during the forecast period. By application, the research and development (R&D) or process development segment led the market in 2024. By application, the bioproduction segment is expected to be the fastest-growing during 2025-2034. By usage, the lab-scale production segment led the single-use bioreactors market in 2024. By usage, the large-scale production segment is expected to grow significantly in the projected period. By end-use, the CMOs & CROs segment held a major revenue share of the market in 2024. By end-use, the pharmaceutical and biopharmaceutical companies segment is expected to register significant growth during 2025-2034. Market Overview & Potential Primarily, single-use bioreactors are disposable, pre-sterilized bioreactors established for cell culture and microbial fermentation. Furthermore, providing benefits, including minimized contamination risk, minimal capital expenditure, and quicker turnaround times compared to conventional stainless steel systems. The single-use bioreactors market possesses numerous applications in the biopharmaceutical industry for the manufacturing of different biologics like vaccines, monoclonal antibodies, and recombinant proteins. Besides this, in 2025, the market will boost automation, scalability, and process control, with the launch of novel models and features. Report Scope Metric Details Market Size in 2024 USD 4.59 Billion Projected Market Size in 2034 USD 22.46 Billion CAGR (2025 - 2034) 17.21 % Leading Region North America Market Segmentation By Product, By Type, By Type of Cell, By Molecule Type, By Application, By Usage Type, By End-use, By Region Top Key Players Sartorius Stedim Biotech, Thermo Fisher Scientific, Danaher, Merck KgaA, Celltainer Biotech BV, Getinge AB, Eppendorf AG, Cellexus, PBS Biotech Inc., Distek Inc., ABEC, Able Corporation & Biott Corporation, G&G Technologies Inc., Solida Biotech GmbH, Satake Chemical Equipment Mfg., Ltd., Stobbe Pharma GmbH, bbi-biotech GmbH You can place an order or ask any questions, please feel free to contact us at sales@ What are the Key Drivers in the Developing Market? Across the single-use bioreactors market, several factors contribute to the expansion, such as it has affordability and enhanced efficiency. Other drivers involved in the comprehensive development of the market are the growing innovations in bioreactor design and the emergence of large-scale single-use bioreactors. Apart from this, the rising demand for diverse biologics, like monoclonal antibodies, vaccines, and cell & gene therapies, is fueling the adoption of single-use bioreactors. What are the Trends in the Single-Use Bioreactors Market? The market is experiencing major growth due to accelerating pharmaceutical R&D expenses and the movement towards sustainable manufacturing practices. In March 2025, the collaboration, named Project Nexus, secured £1.4 million in funding from Innovate UK's Sustainable Medicines Manufacturing Innovation, focused on cultivating new sustainable materials customized for single-use bioprocessing equipment, like bioreactors. In June 2024, AGC Biologics expanded its single-use bioreactor capacity with progression at the Denmark site. What Is the Arising Challenge in the Market? In the single-use bioreactors market, challenges are developing hurdles in its expansion, such as a consistent requirement for single-use components like bags, filters, etc. accelerate the expenses. Besides this, issues regarding the consistency and reliability of performance from one single-use bag to another, possibly impacting batch-to-batch reproducibility, are another barrier in numerous pharmaceutical companies. Become a valued research partner with us - Regional Analysis Why Did North America Dominate the Market in 2024? In 2024, North America captured the largest revenue share of 35% in the single-use bioreactors market. Due to affordability and rapid turnaround times, reduced cleaning and validation requirements are assisting in the adoption of single-use bioreactors in this region. Along with this, expanding demand and production for biologics, especially monoclonal antibodies, vaccines, and cell and gene therapies, are propelling in the leading pharmaceutical companies of this region. This further supports a rise in efficiency and scalability scalable manufacturing solutions. For instance, In August 2025, Cytiva collaborated with Culture Biosciences, which specializes in cloud-connected bioreactor technology, to support both hardware commercialization and technology development. In January 2025, Sartorius and McMaster University opened a Canadian bioprocessing hub of about a 1,600 square-foot bioprocess research facility in Hamilton, Ontario, about 38 miles south of Toronto. In October 2024, Recipharm and Exela collaborated to expand US sterile injectable production. How is Asia Pacific Growing in Single-use Bioreactors Market? During 2025-2034, the Asia Pacific is anticipated to expand at the fastest CAGR in the single-use bioreactors market. In the ASAP countries, such as China and India, are actively involved in the investment in biopharmaceutical research and development activities, which are further assisting in the emergence of the single-use bioreactors in various bioprocessing. Alongside, Contract Manufacturing Organizations (CMOs) of ASAP are widely adopting single-use bioreactors to enable feasible manufacturing solutions and minimal cross-contamination risks. Adaptable government policies and incentives focused on the development of the biotechnology sector in ASAP countries are further accelerating the market growth. For instance, In June 2025, Hyderabad-based Biological E Limited (BE) partnered with China's Jiangsu Recbio Technology Company Limited to manufacture and distribute a 9-valent Human Papillomavirus (HPV9) vaccine. Get the latest insights on life science industry segmentation with our Annual Membership: Segmental Insights By product analysis How did the Single-Use Bioreactor Systems Dominate the Market in 2024? The single-use bioreactor systems segment registered dominance in the single-use bioreactors market in 2024. The segment is driven by the growing production of biologics and biosimilars. Moreover, many advantages of this system, such as its flexibility, scalability, affordability, and minimal chances of cross-contamination, are influencing overall market growth. Along with this, single-use bioreactors use less water and energy for their operation. On the other hand, the single-use media bags segment is estimated to grow significantly during 2025-2034. These bags are broadly employed in the preparation and storage of sterile media and buffers, which are necessary for cell proliferation and other bioprocessing stages. Also, they are a feasible and effective approach to manage crucial fluids, with the elimination of requirement for need for conventional stainless steel tanks and associated cleaning processes. Along with this, single-use bags are employed in conjunction with chromatography systems in the separation and purification of target molecules. By type analysis Why did the Stirred Tank Subs Segment Lead the Market in 2024? The stirred tank SUBs segment was dominant in the market in 2024 and is estimated to grow at a rapid CAGR in the single-use bioreactors market. This type of bioreactor possesses superior mixing and aeration capabilities, which are important for high-density cell cultures. Involvement of this type of bioreactor in biopharmaceutical manufacturing of monoclonal antibody (MAb) therapies and other biological products is driving the overall segment's growth. Apart from this, stirred tank SUBs have a vital significance in scale-up processes from R&D to production, allied with their inexpensive and minimized risk of contamination. By cell type analysis Which Cell Type Led the Single-Use Bioreactors Market in 2024? The mammalian cells segment held a dominant revenue share of the market in 2024. These types of cells are widely used in the production of complex biologics, including monoclonal antibodies and therapeutic proteins, which are in increasing demand for advanced therapies. This ultimately enhances the adoption of single-use bioreactors. Also, mammalian cells play a crucial role in expressing functional enzymes for therapeutic applications, including enzyme replacement therapies. Eventually, mammalian cells like BHK-21, Vero, and MDCK are applied in the production of viral vaccines for both human and veterinary applications. Whereas, the bacterial cells segment is estimated to witness significant growth during 2025-2034. Widespread applications of bacterial cells in the biopharmaceutical production, like recombinant protein production, are fueling demand for single-use bioreactors to achieve an essential target. In the case of recombinant protein production, bacterial expression systems such as E. coli are incorporated to accelerate the development of insulin and other therapeutic proteins. Derivatives of bacterial antigens are immensely used in vaccine development. By molecule type analysis What Made the Vaccines Segment Dominant in the Market in 2024? In the single-use bioreactors market, the vaccines segment accounted for a major share in 2024. Varied aspects of single-use bioreactors in vaccine development mainly comprise their rapid product development cycles and quicker turnaround times. Moreover, they have decreased risk of cross-contamination among batches, which ultimately ensures greater product purity and consistency, which is impacting as an important aspect in vaccine production. One of the significant factors, such as raising investments in the pharmaceutical R&D sector, is boosting the adoption of single-use bioreactors for novel vaccine development. However, the gene modified cells segment is anticipated to expand rapidly during 2025-2034. The segment is propelled by a huge demand for cell and gene therapies, which are widely used in oncology and rare genetic disorders. Alongside, single-use bioreactors encompass properties to control specific parameters precisely, such as temperature, pH, and oxygen levels, ensuring optimal expansion conditions for gene-modified cells. Examples like wave bioreactors are applied in a rocking motion to evolve a wave-like movement in the culture bag, ensuring efficient mixing and gas exchange. By application analysis Which Application Dominated the Single-Use Bioreactors Market in 2024? The research and development (R&D) or process development segment held the biggest revenue share of the market in 2024. Across the market, the segment consists of broader utilization of single-use bioreactors in R&D to standardize conditions for scaling up production and confirm continuous effectiveness from lab to industrial level. Apart from this, these bioreactors are favourable for small-scale R&D, particularly in testing new cell lines and media formulation. As well as phenomenal advances in single-use bioreactor technology, like optimized mixing and oxygen transfer, are boosting their adoption in R&D. And, the bioproduction segment is predicted to register rapid expansion in the respective market. The feasibility of single-use bioreactors during the delivery, with maintaining their sterility and ready for installation features are streamlines the bioproduction setup process. Other properties of these bioreactors are impacting bioproduction, including the usage of polymers and plastics that must be compatible with cell culture, which are sterilized by the application of gamma irradiation to avoid pH fluctuations. This expansion of bioproduction will also comprise non-invasive sensors that can monitor temperature, dissolved oxygen, and pH, further minimizing the risk of contamination. By usage analysis Why did the Lab-scale Production Segment Hold a Major Share of the Market in 2024? In the single-use bioreactors market, the lab-scale production segment was dominant in 2024. Currently, the increasing focus on the development of precision medicine, which necessitates smaller batch sizes and customized therapies, is immensely influencing this segment expansion. Additionally, the single-use bioreactors greatly support the transformation and optimization of cell lines for different biopharmaceutical applications. In case of lab-scale production, a wide range of profitable approaches involve using these bioreactors, like in research, preclinical studies, or clinical trials. On the other hand, the large-scale production segment is predicted to expand at a notable CAGR during 2025-2034. Various Contract Development and Manufacturing Organizations (CDMOs) and small and medium-sized enterprises (SMEs) are broadly adopting single-use bioreactors due to their cost-effectiveness and minimal operational spending. Furthermore, consistent advances in single-use technologies, like larger-scale bioreactors and improved mixing and oxygen transfer capabilities, are propelling overall market development. Adoption of highly sophisticated sensor technologies and automation is further integrated into single-use systems to expand process monitoring and control, with allowance of process analytical technology (PAT). By end-use analysis How did the CMOs & CROs Segment Dominate the Market in 2024? The CMOs & CROs segment led the single-use bioreactors market in 2024. Primarily, contributing factors are a rise in outsourcing and the advantages of single-use techniques, including their flexibility, inexpensiveness, and accelerated timelines in biopharmaceutical development and manufacturing. However, CMOs and CROs are leveraging these approaches for strong biopharmaceutical production, especially for a variety of product portfolios and quick campaign turnarounds. The pharmaceutical and biopharmaceutical companies segment is anticipated to register notable growth in the future. Many global providers of single-use technology, particularly single-use bioreactors, are also highly enabling optimization of solutions for mammalian cell culture, high cell-density processes, and microcarrier-based processes. Whereas some companies are offering scientific instrumentation, reagents, consumables, and software, with the inclusion of single-use bioreactors for numerous applications. In several companies, single-use bioreactors are suitable for biopharmaceutical production, mainly for the production of monoclonal antibodies and other biologics. Recent Developments In February 2025, US-based Sunflower Therapeutics announced its foremost distribution agreement with PharmNXT Biotech, an Indian bioprocessing company, to launch its Daisy Petal Perfusion Bioreactor System in Asia, a crucial step in the company's ongoing product commercialization. In September 2024, Culture Biosciences, a developer of automated bioprocess development tools, collaborated with Google Cloud, which will integrate Culture's real-time data monitoring and cloud-connected bioreactors with Gemini AI and other advanced data tools designed by Google. Browse More Insights of Towards Healthcare: The global single cell sequencing market was valued at US$ 1.63 billion in 2024 and is projected to reach US$ 1.88 billion in 2025. By 2034, the market is anticipated to surpass US$ 6.65 billion, expanding at a steady CAGR of 15.05%. The global single-use assemblies market stood at USD 13.25 billion in 2024 and is forecast to grow to USD 15.39 billion in 2025. It is expected to achieve nearly USD 58.44 billion by 2034, progressing at a CAGR of 16.15% between 2025 and 2034. The global single-cell biotherapeutics market is witnessing an upward growth trend and is expected to generate significant revenue, potentially scaling into the hundreds of millions over the forecast period of 2025–2034. The global single-use downstream bioprocessing market was valued at USD 1.57 billion in 2024, rising to USD 1.79 billion in 2025, and is estimated to reach around USD 5.9 billion by 2034, advancing at a CAGR of 14.24% during 2025–2034. The global single-use sensors market was worth USD 0.47 billion in 2024 and is projected to increase to USD 0.54 billion in 2025. By 2034, it is expected to climb to about USD 1.86 billion, recording a CAGR of 15.04% between 2025 and 2034. The global single cell analysis market reached USD 5.19 billion in 2024 and is expected to grow to USD 6.16 billion in 2025. By 2034, the market is forecast to attain USD 29.15 billion, expanding rapidly at a CAGR of 18.74% over the period. The global single nucleotide polymorphism (SNP) genotyping market was valued at USD 6.48 billion in 2024, increasing to USD 7.24 billion in 2025, and is projected to reach nearly USD 19.48 billion by 2034, with a CAGR of 11.7% between 2025 and 2034. The global single-cell omics market accounted for US$ 1.94 billion in 2024, growing to US$ 2.35 billion in 2025. By 2034, it is forecast to generate around US$ 12.05 billion, advancing at a CAGR of 16.14%. The global single-use pump market was valued at US$ 451.81 million in 2023 and is projected to reach approximately US$ 2.13 billion by 2034, expanding at a CAGR of 15.95% during 2024–2034. The global single-use bioprocessing market is anticipated to grow from USD 30.77 billion in 2025 to nearly USD 112.2 billion by 2034, registering a CAGR of 15.46% over the forecast period. Single-Use Bioreactors Market Key Players Sartorius Stedim Biotech Thermo Fisher Scientific Danaher Merck KgaA Celltainer Biotech BV Getinge AB Eppendorf AG Cellexus PBS Biotech Inc. Distek Inc. ABEC Able Corporation & Biott Corporation G&G Technologies Inc. Solida Biotech GmbH Satake Chemical Equipment Mfg., Ltd. Stobbe Pharma GmbH bbi-biotech GmbH Segments Covered in The Report By Product Single-use Bioreactor Systems Up to 10L 11-100L 101-500L 501-1500L Above 1500L Single-use media bags 2D Bags 3D Bags Others Single-use Filtration Assemblies Other Products By Type Stirred-tank SUBs Wave-induced SUBs Bubble-column SUBs Other SUBs By Type of Cell Mammalian Cells Bacterial Cells Yeast Cells Other Cells By Molecule Type Monoclonal Antibodies Vaccines Gene Modified Cells Stem Cells Other Molecules By Application Research and Development (R&D) or Process Development Bioproduction By Usage Type Lab-scale Production Pilot-scale Production Large-scale Production By End-use Pharmaceutical & Biopharmaceutical Companies CROs & CMOs Academic & Research Institutes By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Immediate Delivery Available | Buy This Premium Research @ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region: +44 778 256 0738 North America Region: +1 8044 4193 44 Web: Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

‘No Colon, Still Rollin'': Cass Bargell, US scrum-half and ostomy advocate, sets sights on World Cup
‘No Colon, Still Rollin'': Cass Bargell, US scrum-half and ostomy advocate, sets sights on World Cup

Yahoo

time10 hours ago

  • Yahoo

‘No Colon, Still Rollin'': Cass Bargell, US scrum-half and ostomy advocate, sets sights on World Cup

A few years ago, Cass Bargell gave a Ted Talk at Harvard, the same university where she studied integrative biology and played scrum-half, helping the Crimson to a national 15s title and earning nominations for US player of the year. Onstage, visibly nervous, she clutched a rugby ball as if for emotional support. 'I dropped the ball,' she says, laughing. 'They edited it out.' Bargell didn't drop the ball with her talk, which offered a compelling account of her traumatic experience with ulcerative colitis and her extraordinary recovery. It all began in late 2020, with alarming symptoms. Bargell kept playing through quickening pain but eventually, in November 2021, underwent ileostomy surgery to remove her colon and create a stoma, an opening in her abdomen to allow waste to pass. Just a few months later Bargell was back playing rugby, the sport she found as a middle-schooler in Summit, Colorado, as aggressive as ever but now wearing an ostomy bag. The title of her Ted Talk sums up her determination and her emergence as an advocate for life after surgery: No Colon, Still Rollin'. She has told her remarkable tale many times, including to former NFL Man of the Year and fellow patient Rolf Benirschke, for The Phoenix, official magazine of the United Ostomy Associations of America. But now, at 25 and eight times capped, Bargell is about to step onto the biggest stage of all – the 2025 Women's Rugby World Cup in England, where the US kick-off against the hosts on Friday. Speaking to the Guardian, she said that though life with an ostomy had not 'gotten any easier … I think I've gotten a lot better at handling it. 'I think some things have actually gotten harder, in some ways. The longer I've had it, the more it feels like this daunting thing that's gonna go on for ever. And I think I have, like, those big emotional moments, but I'm a lot better at handling it day to day. I don't think about my bag and I know how to change it much faster now. I know how to handle my supplies.' Related: World Cup final to be most attended women's rugby match in history after ticket sellout Bargell's play gives no clues of her extra burden. In Washington in July against Fiji, as the Americans struggled to hold a narrowing lead, the 5ft 4in dynamo forced two crucial turnovers, stealing Fijiana ball at the ruck. Turning to the nearest reporter to ask 'Who's that flanker the Eagles brought on?', the Guardian was swiftly enlightened: not only was Bargell not a forward, but also, 'that's nothing: she plays with an ostomy bag.' Asked if that played on her mind during games, she said: 'No, I don't think about it. But I'm really lucky that I'm supported by my coaches too. 'When I'm playing and I get hit in the bag, I don't feel anything, I don't think anything. I just put the ball back strongly. But if we're in training and we're doing a drill … where we come up and hit each other and then backpedal, reload, come up at each other again, backpedal, reload, just like working on the constant up and back, as the attacker I was just getting hit straight in the bag over and over and over, and I was like, this never happens to me in a game, and I'm really uncomfortable. 'I wasn't hurt from it or anything. I just was like, that's wearing my bag down more than I need. And my coaches are like, perfect. 'No problem. You'll hold the pad next time.' So then everyone was in the line and I just had a [tackle] pad, and it was fine. 'So it's not like I love getting hit in the bag repetitively. It's just that when it happens, it's not a big deal. I also feel like my right fend has gotten much stronger since I got my ostomy. I don't like people getting that close, so when I can avoid it, I do.' She laughs again, and switches from hand-offs to helping hands, saluting the influence of Ilona Maher, the US center, Olympic sevens medalist and social media star who has fired global interest in the women's game. 'Ilona, the version you see on the internet is how she is,' Bargell says. 'She's, like, a fun, big personality. And also everything she says about there needs to be more stars [in women's rugby] and we need to lift more women up, she lives that and walks it with us. She's helped me so much with sharing my story, with all the social media stuff and everything she talks about in that world. 'On the field, she's fast and she's powerful and she's strong and she can pass, and she brings so much to our team. I love training with her. She's also a really strong organizer, which I don't think people can always see, but she does communicate a lot and helps us all.' Bargell, Maher and the rest of the Eagles may need all the help they can get on Friday: England are favorites to win the World Cup, having crushed rivals France in their final warm-up while the US lost to Canada, another title contender. Looking at that game, Bargell identified a failing familiar from the meeting with Fiji in DC: a strong start not maintained. 'The first half felt easy,' says Bargell, who will start on the bench behind Olivia Ortiz on Friday. 'It felt like that's what we practiced in training, and it was just about executing it. 'We've been working a lot on finding our energy right after half-time and being able to come out and start the second half the way we started the first half, because it really wasn't like we weren't surprising ourselves with what we were doing that first half. It was what we practiced. And so it's just about finding a way to keep that energy throughout the whole game.' 'We really rise' Bargell is one of many Eagles who this year played in Women's Elite Rugby, the semi-pro league which has just completed its first season, with Bargell turning out for the Boston Banshees while working as a data analyst for the Crohn's and Colitis Foundation. She speaks favorably of WER as a step up from the amateur game, if not at the level of Premiership Women's Rugby, where senior Eagles including Ortiz play, where Maher shone for Bristol, and in which England's Red Roses ply their fearsome trade. 'I think an interesting part about our team is that we really rise,' Bargell says. 'We rise to the occasion. And so I know we'll rise [against England]. 'It's an incredible opportunity to be a part of that opening match at all, and I know everyone's really excited for it. We've honestly just been focused on building our own systems. It's not like these past three weeks were only focused on England.' True: Australia and Samoa also await, two wins most likely needed to make the quarter-finals. Australia offer the sterner test. In Perth in May, the Wallaroos downed the Eagles, 29-17. Bargell remains confident. 'We all believe we have a lot of threats, and like who we are as players,' she says. 'And so if we can bring our team together in that way, then we can compete.'

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research
The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Yahoo

time17 hours ago

  • Yahoo

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Philadelphia-led consortium is selected to tailor HIV curative strategies to participant Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute announces the National Institutes of Health (NIH) granted a five-year, $17 million research award to launch iCure Consortium to develop individualized 'cure regimens' for HIV. The Wistar-led, iCure Consortium's objective is to advance strategies to cure HIV through tailored personalized medicine. 'Today 38 million people still live with HIV worldwide, and 1.3 million contract the virus each year,' said Luis J. Montaner, D.V.M., iCure principal investigator, executive vice president of The Wistar Institute and director of Wistar's HIV Cure and Viral Diseases Center. 'For the first time, this grant brings our best team together working towards a cure tailored to each participant by pairing the latest in neutralizing antibody and cell-therapy breakthroughs against the unique, person-specific features of HIV.' iCure Consortium will test a six-part, individually-tailored therapy designed to wipe out the persistent viral reservoir that remains after antiretroviral therapy in an effort to deliver durable, drug-free remission. The project combines six advanced tactics—neutralizing antibodies, mRNA therapy, viral binders, engineered CAR-T and 'Natural Killer' (NK) cells, and precision latency 'wake-up' drugs—all designed against each patient's unique virus. 'Ending HIV demands more than management—it demands eradication,' said Drew Weissman, M.D., Ph.D., iCure co‑principal investigator, 2023 Nobel Laureate and Roberts Family Professor in Vaccine Research at the Perelman School of Medicine at the University of Pennsylvania. 'This project now allows us to apply our breakthroughs in RNA therapy as part of a cure-directed strategy.' How iCure Works• Wake the latent virus• Map and target unique weak spots with tailored antibodies• Destroy infected cells using 'super‑charged' CAR‑T and NK cells• Enhance clearance and block relapse with bispecific binders In the first step, researchers reactivate the virus in a sample of the participant's blood and identify mutations that the participant has not yet developed antibodies against. They then develop a tailored antibody therapy cocktail specifically designed against these specific mutations. In the next stage, researchers focus on preventing HIV from returning. To do this, they develop person-specific antibodies or small molecule binders that can act as 'homing devices' — beacons that can lead immune cells to the latent virus. Then they genetically modify CAR-T cells and NK cells (immune cells that destroy viruses) to express or use these homing devices to better clear infected cells. Finally, researchers further enhance NK cells. First, they develop stronger and more durable cells, called adaptive NK cells, by supercharging their virus-killing ability. Then, they deploy small-molecule drugs called bispecifics, which bind NK cells to the infected cells they are targeting. "iCure takes full advantage of the advances made in understanding how and where HIV hides from the immune system," said Montaner. "We've built on our knowledge and can use that information to identify a first of its kind targeting to a person's unique HIV features." iCure furthers the research groundwork laid by the BEAT-HIV Martin Delaney Collaboratory ( a Philadelphia-based consortium of more than 95 leading HIV researchers co-led by Dr. Montaner. Montaner called the NIH grant a 'once in a lifetime opportunity' that reflects Wistar's track record as a scientific leader in the effort to develop an HIV cure, as well as its grassroots support and collaboration with the HIV community. 'By the end of this study we hope to have a process by which to identify the virus that we need to go after in each person and have a basis to design clinical trials choosing the best of these strategies to move forward,' said Montaner. Other institutions participating in this study include Johns Hopkins Medicine and iCure co-principal investigator Robert Siliciano, M.D., Ph.D., the University of Pennsylvania, Philadelphia FIGHT, the Ragon Institute at Harvard University, George Washington University, Duke University, and Massachusetts Institute of Technology. The iCure program is funded by the National Institute of Allergy and Infectious Diseases, part of NIH, under award number UM1AI191272. ### The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. CONTACT: Darien Sutton The Wistar Institute 215-870-2048 dsutton@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store